PortfoliosLab logoPortfoliosLab logo

Sharpe ratio is not yet available for COEPW. This metric requires at least 12 months of historical daily returns to calculate. Check back once this data is available.

How it compares to other similar stocks

The table compares Coeptis Therapeutics Holdings Inc's Sharpe Ratio with other stocks in the Biotechnology industry across multiple time periods, showing how COEPW's risk-adjusted performance compares to industry peers.

Data shows 1-, 5-, and 10-year periods, plus each stock's all-time average, as of Jun 6, 2026.


SymbolName1Y Sharpe Ratio5Y Sharpe Ratio10Y Sharpe RatioAll Time Sharpe Ratio
RVMDWRevolution Medicines Inc. Warrant12.40
SLGLSol-Gel Technologies Ltd.9.82
CLYMClimb Bio Inc7.60
ERASErasca, Inc.6.43
NBTXNanobiotix S.A.6.19
OVIDOvid Therapeutics Inc.5.93
DRTSWAlpha Tau Medical Ltd. Warrant5.77
TNGXTango Therapeutics, Inc.5.49
ARWRArrowhead Pharmaceuticals, Inc.5.32
ANROAlto Neuroscience, Inc5.27
COEPWCoeptis Therapeutics Holdings Inc

S&P 500 Index

How to choose period

Historical Sharpe Ratio

The chart shows COEPW's rolling Sharpe ratio over time compared to your chosen benchmark. Rising trends indicate improving returns relative to total volatility, while declining trends may signal deteriorating risk-adjusted performance or increased volatility. Use multiple timeframes to distinguish short-term fluctuations from long-term patterns.

Identify market cycles by observing when COEPW consistently outperforms (line above benchmark), underperforms (below benchmark), or aligns with the benchmark.


Loading charts...

Sharpe Ratio Calculator

How does COEPW fit in your portfolio?

Add your other holdings to see your portfolio's Sharpe Ratio and find out.

Analyze Your Portfolio